0
ARTICLE |

Diagnostic and Therapeutic Technology Assessment (DATTA)

JAMA. 1992;267(21):2948-2952. doi:10.1001/jama.1992.03480210110043.
Text Size: A A A
Published online

Extract

Rutherford GW, Lifson AR, Hessol NA, et al.  Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11-year follow-up study. BMJ . 1990;301: 1183-1188.
Link to Article[[XSLOpenURL/10.1136/bmj.301.6762.1183]]
Burke DS, Redfield RR.  The stages of HIV infection: a predictable, progressive disease.  In Rapoza N, ed. HIV Infection and Disease . Chicago, Ill: American Medical Association; 1989:1-11.
Sears SD, Fox R, Brookmeyer R, Leavitt R, Polk BF.  Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol . 1987;45:177-183.
Link to Article[[XSLOpenURL/10.1016/0090-1229(87)90032-8]]
Gottlieb MS, Schroff R, Schanker HM, et al.  Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med . 1981;305:1425-1431.
Link to Article[[XSLOpenURL/10.1056/NEJM198112103052401]]
Fauci AS, Macher AM, Longo DL, et al.  NIH Conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic and therapeutic considerations. Ann Intern Med . 1984;100:92-106.
Link to Article[[XSLOpenURL/10.7326/0003-4819-100-1-92]]
Koenig SM, Fauci AS.  Pathogenesis of AIDS.  In Rapoza N, ed. HIV Infection and Disease . Chicago, Ill: American Medical Association; 1989:71-85.
Seligmann M, Chess L, Fahey JL, et al.  AIDS: An immunologic reevaluation. N Engl J Med . 1984;311:1286-1292.
Link to Article[[XSLOpenURL/10.1056/NEJM198411153112005]]
Springer TA.  Adhesion receptors of the immune system. Nature . 1990;346:425-434.
Link to Article[[XSLOpenURL/10.1038/346425a0]]
Sattentau QJ, Weiss RA.  The CD4 antigen: physiological ligand and HIV receptor. Cell . 1988;52:631-633.
Link to Article[[XSLOpenURL/10.1016/0092-8674(88)90397-2]]
Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA.  The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature . 1984;312:763-766.
Link to Article[[XSLOpenURL/10.1038/312763a0]]
Jameson BA, Rao PE, Kong LI, et al.  Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science . 1988;240:1335-1339.
Link to Article[[XSLOpenURL/10.1126/science.2453925]]
Fahey JL, Prince H, Weaver M, et al.  Quantitative changes in T helper or T suppressor/cytotoxic lymphocyte subsets that distinguish acquired immune deficiency syndrome from other immune subset disorders. Am J Med . 1984;76:95-100.
Link to Article[[XSLOpenURL/10.1016/0002-9343(84)90756-3]]
Polk BF, Fox R, Brookmeyer R, et al.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med . 1987;316:61-66.
Link to Article[[XSLOpenURL/10.1056/NEJM198701083160201]]
Goerdert JJ, Biggar RJ, Melbye M, et al.  Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA . 1987;257:331-334.
Link to Article[[XSLOpenURL/10.1001/jama.1987.03390030061021]]
Masur H, Ognibene FP, Yarchoan R, et al.  CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med . 1989;111:223-231.
Link to Article[[XSLOpenURL/10.7326/0003-4819-111-3-223]]
Fahey JL, Taylor JMG, Detels R, et al.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med . 1990;322:166-172.
Link to Article[[XSLOpenURL/10.1056/NEJM199001183220305]]
Melbye M, Biggar RJ, Ebbesen P, et al.  Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities: a longitudinal study. Ann Intern Med . 1986;104:496-500.
Link to Article[[XSLOpenURL/10.7326/0003-4819-104-4-496]]
Jacobson MA, Bacchetti P, Kolokathis A, et al.  Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ . 1991;302:73-78.
Link to Article[[XSLOpenURL/10.1136/bmj.302.6768.73]]
Aledort LM.  Serial CD4 counts in relation to the decision to treat asymptomatic HIV-1 infection.  In: Program and abstracts of the VII International AIDS Conference ; June 1991; Florence, Italy. Abstract MB 35.
Nicholson JKA, Jones BM.  Immunophenotyping by flow cytometry: its use in HIV infection. Labmedica . 1989:21-26.
Revised Classification System for HIV Infection and Expanded AIDS Surveillance Case Definition for Adolescents and Adults . Atlanta, Ga: US Dept of Health and Human Services, Centers for Disease Control; 1992. Draft dated November 15,1991.
Miller-Catchpole R, Rapoza NP.  Prophylactic treatment for opportunistic infections in HIV-positive patients: aerosolized pentamidine. JAMA . 1990;263:2510-2514.
Link to Article[[XSLOpenURL/10.1001/jama.1990.03440020069027]]
Kovacs A, Frederick T, Church J, Eller A, Oxtoby M, Mascola L.  CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection. JAMA . 1991;265:1698-1703.
Link to Article[[XSLOpenURL/10.1001/jama.1991.03460130090028]]
Jacobson MA, Besch CL, Child C, Hafner R, Muth K, Beyton L.  Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii infection. Eur J Clin Microbiol Infect Dis . 1991;10:195-198.
Link to Article[[XSLOpenURL/10.1007/BF01964462]]
Di Perri G, Micciolo R, Vento S, Cruciani M, Concia E, Bassetti D.  CD4 count as predictor of reactivation of tuberculosis in HIV infection.  In: Program and abstracts of the VII International AIDS Conference ; June 1991; Florence, Italy. Abstract WB 2359.
Fischl MA, Richman DD, Grieco MH.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. N Engl J Med . 1987;317:185-191.
Link to Article[[XSLOpenURL/10.1056/NEJM198707233170401]]
Cotton P.  HIV surrogate markers weighted. JAMA . 1991;265:1357-1362.
Link to Article[[XSLOpenURL/10.1001/jama.265.11.1357]]
Jacobson MA, Abrams DI, Volberding PA, et al.  Serum β2-microglobulin decreases in patients with AIDS or ARC treated with azidethymidine. J Infect Dis . 1989;159:1029-1036.
Link to Article[[XSLOpenURL/10.1093/infdis/159.6.1029]]
Paul WE. Fundamental Immunology . New York, NY: Raven Press; 1984.
Vitiello A, Potter TA, Sherman LA.  The role of beta 2-microglobulin in peptide binding by class I molecules. Science . 1990;250:1423-1426.
Link to Article[[XSLOpenURL/10.1126/science.2124002]]
Perarnau B, Siegrist CA, Gillet A, Vincent C, Kimura S, Lemonnier FA.  Beta 2-microglobulin restriction of antigen presentation. Nature . 1990;346:751-754.
Link to Article[[XSLOpenURL/10.1038/346751a0]]
Zolla-Pazner S, William D, El-Sadr W, Marmor M, Stahl R.  Quantitation of beta 2-microglobulin and other immune characteristics in a prospective study of men at risk for acquired immune deficiency syndrome. JAMA . 1984;251:2951-2955.
Link to Article[[XSLOpenURL/10.1001/jama.1984.03340460029020]]
Moss AR, Bacchetti P, Osmond D, et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ . 1988;296:745-750.
Link to Article[[XSLOpenURL/10.1136/bmj.296.6624.745]]
Chan MM, Campos JM, Josephs S, Rifai N.  Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children. J Clin Microbiol . 1990;28:2215-2219.
Falloon J, Eddy J, Weiner L, Pizzo PA.  Human immunodeficiency virus infection in children. J Pediatr . 1989;114:1-30.
Link to Article[[XSLOpenURL/10.1016/S0022-3476(89)80596-7]]
Massironi E, D'Arminio MA, Marchisio P, et al.  Beta-2 microglobulin and neopterin as markers of zidovudine efficacy in HIV infected symptomatic children.  In: Program and abstracts of the VII International AIDS Conference ; June 1991; Florence, Italy. Abstract WB 2024.
Forman DT.  Beta 2-microglobulin: an immunogenetic marker of inflammatory and malignant origin. Ann Clin Lab Sci . 1982;12:447-452.
Huber C, Batchelor JR, Fuchs D, et al.  Immune response-associated production of neopterin: release from macrophages primarily under control of interferongamma. J Exp Med . 1984;160:310-316.
Link to Article[[XSLOpenURL/10.1084/jem.160.1.310]]
 Neopterins in clinical medicine. Lancet . 1988;1:509-511. Editorial.
Melmed RN, Taylor JM, Detels R, Bozorgmehri M, Fahey JL.  Serum neopterin changes in HIV-infected subjects: indication of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr . 1989;2:70-76.
Fuchs D, Hausen A, Reibnegger G, et al.  Urinary neopterin in the diagnosis of acquired immune deficiency syndrome. Eur J Clin Microbiol . 1984;3:70-71.
Link to Article[[XSLOpenURL/10.1007/BF02032832]]
Perna M, Nitsch F, Santelli G, et al.  Urinary neopterin, a useful marker for AIDS? Lancet . 1985;1:1048.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(85)91652-6]]
Griffin DE, McArthur JC, Cornblath DR.  Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology . 1991;41:69-74.
Link to Article[[XSLOpenURL/10.1212/WNL.41.1.69]]
Rautonen J, Martin NL, Rautonen N, Wara DW.  Neopterin in diagnosis of human immunodeficiency virus infection in infants. J Clin Microbiol . 1991;29:850.
Greene WC.  The molecular biology of human immunodeficiency virus type 1 infection. N Engl J Med . 1991;324:308-317.
Link to Article[[XSLOpenURL/10.1056/NEJM199101313240506]]
Goudsmit J, de Wolf F, Paul DA, et al.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet . 1986;2:177-180.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(86)92485-2]]
Kessler HA, Blaauw B, Spear J, Paul DA, Falk LA, Landay A.  Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA . 1987;258:1196-1199.
Link to Article[[XSLOpenURL/10.1001/jama.1987.03400090080038]]
Allain JP, Laurian Y, Paul DA, Senn D.  Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet . 1986;2:1233-1236.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(86)92673-5]]
Gaines H, Sönnerborg A, Czajkowski J, et al.  Antibody response in primary human immunodeficiency virus infection. Lancet . 1987;2:1249-1253.
Link to Article[[XSLOpenURL/10.1016/S0140-6736(87)92696-1]]
Farzadegan H, Polis MA, Wolinsky SM, et al.  Loss of human immunodeficiency virus type 1 (HIV-I) antibodies with evidence of viral infection in asymptomatic homosexual men: a report from the Multicenter AIDS Cohort Study. Ann Intern Med . 1988;108:785-790.
Link to Article[[XSLOpenURL/10.7326/0003-4819-108-6-785]]
Lange JM, Coutinho RA, Krone WJ, et al.  Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotrophic virus. BMJ . 1986;292:228-230.
Link to Article[[XSLOpenURL/10.1136/bmj.292.6515.228]]
Lange JM, Paul DA, Huisman HG, et al.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. BMJ . 1986;293: 1459-1462.
Link to Article[[XSLOpenURL/10.1136/bmj.293.6560.1459]]
Allain JP, Laurian Y, Paul DA, et al.  Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: potential clinical importance. N Engl J Med . 1987;317:114-121.
Link to Article[[XSLOpenURL/10.1056/NEJM198710293171804]]
Cao YZ, Valentine F, Hojvat S, et al.  Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood . 1987;70:575-578.
Pedersen C, Nielsen CM, Vestergaard BF, Gerstoft J, Krogsgaard K, Neilsen JO.  Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. BMJ . 1987;295:567-569.
Link to Article[[XSLOpenURL/10.1136/bmj.295.6598.567]]

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();